Jinxin oral liquid inhibits human respiratory syncytial virus-induced excessive inflammation associated with blockade of the NLRP3/ASC/Caspase-1 pathway
Cunsi Shen(Nanjing University of Chinese Medicine), Jinjun Shan(Nanjing University of Chinese Medicine), Kang An(Nanjing University of Chinese Medicine), Qigang Dai(Jiangsu Provincial Center for Disease Control and Prevention), Zhengguang Zhang(Nanjing University of Chinese Medicine), Jianjian Ji(Nanjing University of Chinese Medicine), Tong Xie(Nanjing University of Chinese Medicine), Jianya Xu(Nanjing University of Chinese Medicine), Jing Yan(Jiangxi Pingxiang People's Hospital), Shouchuan Wang(Nanjing University of Chinese Medicine)
Cited by 25
Related Papers
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2009|254
FÖrster resonance energy transfer (FRET)-based biosensors for biological applications
|Biosensors and Bioelectronics|2019|228
Rapid identification of ophiopogonins and ophiopogonones in Ophiopogon japonicus extract with a practical technique of mass defect filtering based on high resolution mass spectrometry
|Journal of Chromatography A|2012|127
Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy
|Journal of Neuroinflammation|2011|104